Victa Biotherapeutics Appoints Donald W. Kufe to Board of Directors - businesswire.com -BoardProspects

Victa Biotherapeutics Appoints Donald W. Kufe to Board of Directors

businesswire.com Feb 12 2019 BoardMoves

CAMBRIDGE, Mass.--(BUSINESS WIRE)--HiFiBiO Therapeutics, a world leader in the discovery and development of therapeutic antibodies enabled ...
Read Full Article

Bookmark or Share this article

Login to comment.
Related Articles
- Pandora Jewelry Names New CEO and Board Chairman also categorized in BoardMoves
- What Lies Ahead For Chesapeake As McClendon Exits? also categorized in BoardMoves
- The CIO-Plus Of Vivint Smart Home Named To The Board Of Domo also categorized in BoardMoves
- Airbnb Adds Outgoing American Express CEO Kenneth Chenault To Board of Directors also categorized in BoardMoves
- Pfizer Spinoff Zoetis Takes Pershing Square's Doyle Onto Board also categorized in BoardMoves
- Cherry Murray, Ph.D., Harvard Engineering Dean, Joins Board of Directors of Newport Corporation also mentions Harvard
- PepsiCo Puts Trian Business Advisor On Board also categorized in BoardMoves
- Cloud Foundry Board Elects EMC CTO As Chair also categorized in BoardMoves
- Accomplished Lawyer Returns to Fulbright's Houston Office also published in businesswire.com
- Honest Company Diversifies Its Leadership With A Second Female Board Member also categorized in BoardMoves

Search:
Categories
1. BoardProspects Features:
  BoardBlogs, BoardKnowledge, BoardMoves, BoardNews, BoardProspects Announcements, BoardProspects CEO, CEO Blog, Competitor Corner, In the News, Partner Publications, Question of The Week, Sponsored Content
Quotes
1. I have known Don personally for 35 years and his translational pharmacology research has been instrumental in the development of breakthrough vaccines and cancer medicines.
2. Victa Biotherapeutics offers a unique combination of visionary scientists from academia and industry and proven single-cell analysis platform, enabling it to quickly take advantage of the many incredible advances in immuno-oncology research and better connect biological targets to patient characteristics.
Topics Mentioned